ETV

Serial Number 87581401
Registration 6251665
700

Registration Progress

Application Filed
Aug 23, 2017
Under Examination
Mar 6, 2018
Approved for Publication
Jan 9, 2018
Published for Opposition
Jan 9, 2018
Registered
Jan 19, 2021

Trademark Image

ETV

Basic Information

Serial Number
87581401
Registration Number
6251665
Filing Date
August 23, 2017
Registration Date
January 19, 2021
Published for Opposition
January 9, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 19, 2021
Registration
Registered
Classes
005

Rights Holder

Denali Therapeutics Inc.

03
Address
161 Oyster Point Boulevard
South San Francisco, CA 94080

Ownership History

Denali Therapeutics Inc.

Original Applicant
03
South San Francisco, CA

Denali Therapeutics Inc.

Owner at Publication
03
South San Francisco, CA

Denali Therapeutics Inc.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
Chelseaa Larsen

USPTO Deadlines

Next Deadline
558 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-01-19)
Due Date
January 19, 2027
Grace Period Ends
July 19, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

40 events
Date Code Type Description
Feb 4, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 4, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 4, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 19, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 15, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 14, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 23, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Nov 19, 2020 IUAF S USE AMENDMENT FILED
Nov 19, 2020 EISU I TEAS STATEMENT OF USE RECEIVED
Aug 14, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 13, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 13, 2020 EX5G S SOU EXTENSION 5 GRANTED
Jul 29, 2020 EXT5 S SOU EXTENSION 5 FILED
Jul 29, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 29, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 19, 2020 EX4G S SOU EXTENSION 4 GRANTED
Feb 19, 2020 EXT4 S SOU EXTENSION 4 FILED
Feb 19, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 29, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2019 EX3G S SOU EXTENSION 3 GRANTED
Aug 27, 2019 EXT3 S SOU EXTENSION 3 FILED
Aug 27, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 20, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 20, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 1, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2019 EX2G S SOU EXTENSION 2 GRANTED
Feb 27, 2019 EXT2 S SOU EXTENSION 2 FILED
Feb 27, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 25, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 23, 2018 EX1G S SOU EXTENSION 1 GRANTED
Aug 23, 2018 EXT1 S SOU EXTENSION 1 FILED
Aug 23, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 6, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 9, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2018 PUBO A PUBLISHED FOR OPPOSITION
Dec 20, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 28, 2017 DOCK D ASSIGNED TO EXAMINER
Aug 29, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 26, 2017 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for diagnosing and treating diseases of the central nervous system
First Use Anywhere: Nov 9, 2020
First Use in Commerce: Nov 9, 2020

Classification

International Classes
005